COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. [electronic resource]
Producer: 20040506Description: 14-22 p. digitalISSN:- 0940-1334
- Analysis of Variance
- Antigens, CD -- blood
- Antipsychotic Agents -- therapeutic use
- Celecoxib
- Cyclooxygenase Inhibitors -- therapeutic use
- Cytokines -- blood
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Flow Cytometry -- methods
- Humans
- Male
- Psychiatric Status Rating Scales
- Pyrazoles
- Receptors, Interleukin-2 -- blood
- Receptors, Tumor Necrosis Factor -- blood
- Receptors, Tumor Necrosis Factor, Type I
- Risperidone -- therapeutic use
- Schizophrenia -- drug therapy
- Sulfonamides -- therapeutic use
- T-Lymphocytes -- drug effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.